We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+9.66%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$39.4B
AUM Growth
+$3.78B
(+11%)
Cap. Flow
+$934M
Cap. Flow
% of AUM
2.37%
Top 10 Holdings %
Top 10 Hldgs %
22.56%
Holding
1,080
New
75
Increased
361
Reduced
442
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
L3Harris
LHX
|
+$242M |
| 2 |
Illumina
ILMN
|
+$98.3M |
| 3 |
Bio-Rad Laboratories Class A
BIO
|
+$80.6M |
| 4 |
Amazon
AMZN
|
+$63.7M |
| 5 |
Fortive
FTV
|
+$55.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$61.6M |
| 2 |
Mettler-Toledo International
MTD
|
+$54.4M |
| 3 |
Edwards Lifesciences
EW
|
+$47.2M |
| 4 |
Danaher
DHR
|
+$46.2M |
| 5 |
Microsoft
MSFT
|
+$45.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.67% |
| 2 | Healthcare | 17.29% |
| 3 | Financials | 13.57% |
| 4 | Consumer Discretionary | 12.51% |
| 5 | Industrials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Neurocrine Biosciences
NBIX
$17.7B
| $60.5M | 0.15% |
562,986
+3,473
| +0.6% | +$364K |
|
127
Arch Capital
ACGL
$36.1B
| $59.8M | 0.15% |
1,395,077
-2,416
| -0.2% | -$100K |
|
128
Cisco
CSCO
$450B
| $59.6M | 0.15% |
1,243,195
-862
| -0.1% | -$40.1K |
|
129
Crown Castle
CCI
$32.7B
| $58.9M | 0.15% |
414,646
-9,970
| -2% | -$1.36M |
|
130
Casey's General Stores
CASY
$31.9B
| $58M | 0.15% |
365,120
+24,446
| +7% | +$4.05M |
|
131
iShares Russell 1000 Value ETF
IWD
$82B
| $57.3M | 0.15% |
419,953
-18,126
| -4% | -$2.39M |
|
132
Littelfuse
LFUS
$10.2B
| $56.8M | 0.14% |
297,138
+2,093
| +0.7% | +$384K |
|
133
Vanguard S&P 500 ETF
VOO
$968B
| $56.2M | 0.14% |
189,833
+7,248
| +4% | +$2.05M |
|
134
Aptiv
APTV
$12B
| $56.1M | 0.14% |
590,928
-489,959
| -45% | -$44.9M |
|
|
JBTM
135
JBT Marel
JBTM
$7.14B
| $55.4M | 0.14% |
492,176
+79,920
| +19% | +$8.56M |
|
136
Vanguard FTSE Emerging Markets ETF
VWO
$119B
| $55.2M | 0.14% |
1,240,371
-4,440
| -0.4% | -$188K |
|
|
HUD
137
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $54.5M | 0.14% |
3,553,279
-12,967
| -0.4% | -$169K |
|
138
HEICO Corp
HEI
$48.9B
| $54M | 0.14% |
473,107
-54,283
| -10% | -$6.68M |
|
139
Murphy USA
MUSA
$11.3B
| $53.3M | 0.14% |
455,380
-107,801
| -19% | -$11.6M |
|
140
AbbVie
ABBV
$458B
| $52.6M | 0.13% |
593,917
+10,333
| +2% | +$858K |
|
141
Nexstar Media Group
NXST
$5.6B
| $51.9M | 0.13% |
442,575
-35
| -0% | -$3.66K |
|
142
PepsiCo
PEP
$186B
| $50.1M | 0.13% |
366,672
-4,456
| -1% | -$606K |
|
143
Eagle Materials
EXP
$6.6B
| $49.9M | 0.13% |
550,046
-644
| -0.1% | -$59K |
|
144
Coca-Cola
KO
$354B
| $48.6M | 0.12% |
877,943
-3,451
| -0.4% | -$186K |
|
|
STAY
145
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $47.7M | 0.12% |
3,212,121
+21,910
| +0.7% | +$319K |
|
146
HealthEquity
HQY
$7.91B
| $47.1M | 0.12% |
636,033
+331,724
| +109% | +$20.7M |
|
147
Albany International
AIN
$2.14B
| $47M | 0.12% |
618,772
-1,683
| -0.3% | -$140K |
|
148
Automatic Data Processing
ADP
$100B
| $46.9M | 0.12% |
274,958
+4,124
| +2% | +$683K |
|
|
PRO
149
DELISTED
PROS Holdings
PRO
| $46.8M | 0.12% |
781,819
+106,314
| +16% | +$6.13M |
|
150
Maximus
MMS
$3.14B
| $46.3M | 0.12% |
622,457
+559
| +0.1% | +$42K |
|
Similar funds
QCM
Brown Advisory's Q4 2019 Portfolio in Review
As of Q4 2019, Brown Advisory held 1,080 positions worth $39.4B, up 11% from $35.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Brown Advisory's Q4 2019 filing shows 75 new, 361 increased, 442 reduced and 44 closed positions. Its largest new stake was Bio-Rad Laboratories Class A: 228,512 shares worth $84.6M. The largest sale was PayPal, an estimated $61.6M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q4 2019 buy was Bio-Rad Laboratories Class A: 228,512 shares worth $84.6M.
- Brown Advisory added most to L3Harris in Q4 2019, an estimated $242M increase.
- Brown Advisory's biggest Q4 2019 reduction was PayPal, cutting an estimated $61.6M.
- Brown Advisory fully exited Loral Space and Communications, Inc. in Q4 2019, selling an estimated $21.1M.
- Brown Advisory's ten largest holdings make up 23% of its $39.4B portfolio in Q4 2019.
- Brown Advisory opened 75 new positions and closed 44 in Q4 2019.
- Brown Advisory's portfolio value rose 11% quarter-over-quarter to $39.4B.
Based on Brown Advisory's 13F filing for Q4 2019, filed 14 Feb 2020.